Ceryx Medical's
The findings, which have not yet been published in a peer-reviewed journal, add to the growing evidence that GLP-1 agonists a class of medications that includes the popular diabetes and weight loss drugs Ozempic and Wegovy, from Novo Nordisk, and Mounjaro and Zepbound, from Eli Lilly may also protect the brain
NAPRT modulators Apart from the targets discussed above, one of the less explored yet crucial enzymes in NAD + biosynthesis is NAPRT, the rate-limiting enzyme of the PreissHandler pathway
If youre struggling to lose weight or to manage your diabetes, Semaglutide may be a treatment worth considering
Common GLP-1 Inhibitors Some of the most commonly prescribed GLP-1 inhibitors include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Mounjaro) Exenatide (Byetta, Bydureon) These medications are most commonly administered in the form of weekly injections, but there are a few oral formulations available on the market as well
Since weight loss is a major therapeutic goal, patients should record weekly measurements